Kate Haviland, CHIEF EXECUTIVE OFFICER at Blueprint Medicines Corp (BPMC), sold 2,892 shares at $110.24 ($319K) on 2025-01-21, disclosed to the SEC on 2025-01-23.
Scheduled sale ($319k) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $110.24 | 1,446 | $159K | 50.0% |
| 2 | $110.24 | 1,446 | $159K | 50.0% |
| Total | $110.24 avg | 2,892 | $319K | 100% |
| Filing → |
| BPMC | SELL | 2024-12-03 | $396K | — | Filing → |
| BPMC | SELL | 2024-03-11 | $2.3M | — | Filing → |
| BPMC | SELL | 2023-03-08 | $597K | — | Filing → |